These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 19787234

  • 1. Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.
    Kusumoto S, Hirose T, Fukayama M, Kataoka D, Hamada K, Sugiyama T, Shirai T, Yamaoka T, Okuda K, Ohnishi T, Ohmori T, Kadokura M, Adachi M.
    Oncol Rep; 2009 Nov; 22(5):1157-62. PubMed ID: 19787234
    [Abstract] [Full Text] [Related]

  • 2. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T, Mizutani Y, Ohmori T, Ishida H, Hosaka T, Ando K, Shirai T, Okuda K, Ohnishi T, Horichi N, Kubota H, Adachi M.
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
    [Abstract] [Full Text] [Related]

  • 3. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 4. Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.
    Descourt R, Vergnenegre A, Barlesi F, Lena H, Fournel P, Falchero L, Berard H, Hureaux J, Le Caer H, Chavaillon JM, Geriniere L, Monnet I, Chouabe S, Robinet G, GFPC VINCR Team.
    J Thorac Oncol; 2011 Feb; 6(2):351-7. PubMed ID: 21164367
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1037-44. PubMed ID: 16024178
    [Abstract] [Full Text] [Related]

  • 6. Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
    Juan O, Sánchez-Hernández A, Vázquez S, Casal J, Firvida JL, Aparisi F, Muñoz J, García-Sánchez J, Gironés R, Lázaro M, Giner V.
    Anticancer Res; 2014 Apr 15; 34(4):1959-66. PubMed ID: 24692732
    [Abstract] [Full Text] [Related]

  • 7. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 8. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
    Liu D, Zheng X, Chen J, Liu G, Xu Y, Shen Y, Xie L, Zhao W, Jiang G, Fan M.
    Lung Cancer; 2015 Sep 01; 89(3):249-54. PubMed ID: 26118463
    [Abstract] [Full Text] [Related]

  • 9. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
    Pöttgen C, Eberhardt WE, Gauler T, Krbek T, Berkovic K, Jawad JA, Korfee S, Teschler H, Stamatis G, Stuschke M.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):809-15. PubMed ID: 19427744
    [Abstract] [Full Text] [Related]

  • 10. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Mar 01; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

  • 11. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S, Bier A, Thierbach U, Virchow C, Ketterer P, Fietkau R.
    Strahlenther Onkol; 2003 Dec 01; 179(12):823-31. PubMed ID: 14652671
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer.
    Gadgeel SM, Ruckdeschel JC, Patel BB, Wozniak A, Konski A, Valdivieso M, Hackstock D, Chen W, Belzer K, Burger AM, Marquette L, Turrisi A.
    J Thorac Oncol; 2011 May 01; 6(5):927-33. PubMed ID: 21415776
    [Abstract] [Full Text] [Related]

  • 13. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G.
    Lung Cancer; 2004 Aug 01; 45(2):243-53. PubMed ID: 15246197
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
    Felip E, Del Campo JM, Bodi R, Vera R, Casado S, Rubio D.
    Am J Clin Oncol; 1997 Aug 01; 20(4):404-6. PubMed ID: 9256899
    [Abstract] [Full Text] [Related]

  • 15. Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study.
    Nawrocki S, Krzakowski M, Wasilewska-Tesluk E, Kowalski D, Rucinska M, Dziadziuszko R, Sowa A.
    J Thorac Oncol; 2010 Aug 01; 5(8):1255-62. PubMed ID: 20592630
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 01; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 17. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Apr 01; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 18. Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study.
    Fukuda M, Soda H, Fukuda M, Kinoshita A, Nakamura Y, Nagashima S, Takatani H, Tsukamoto K, Kohno S, Oka M.
    Cancer; 2007 Aug 01; 110(3):606-13. PubMed ID: 17577234
    [Abstract] [Full Text] [Related]

  • 19. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J.
    Lung Cancer; 2011 Feb 01; 71(2):166-72. PubMed ID: 20541833
    [Abstract] [Full Text] [Related]

  • 20. Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer.
    Sekine I, Nokihara H, Sumi M, Saijo N, Nishiwaki Y, Ishikura S, Mori K, Tsukiyama I, Tamura T.
    J Thorac Oncol; 2006 Oct 01; 1(8):810-5. PubMed ID: 17409964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.